Gastroesophageal variceal bleeding is a common and life-threatening complication in patients with cirrhosis and portal hypertension. When cirrhosis is diagnosed, varices are present in about 50% of ...

Patients with cirrhosis are at risk of esophageal hemorrhage. The efficacy of endoscopic variceal band ligation (EVBL) for the prophylaxis of initial hemorrhage in patients with cirrhosis is unclear.

The findings of the present study illustrate the importance of technical aspects of endoscopic variceal ligation in influencing the success of secondary prophylaxis. Our results identify a possible ...

Beta blockers should be the first line of prevention against variceal bleeding in patients with cirrhosis and portal hypertension. While banding is similarly effective in reducing the incidence of ...

All patients who underwent EVL for treatment of acute variceal bleeding followed by EVL for secondary prophylaxis and who subsequently developed recurrent variceal bleeding at the Mayo Clinic, ...

Researchers at the Medical University of South Carolina revealed the need to clarify current treatment guidelines for octreotide therapy following an esophageal variceal hemorrhage in a recent study ...

Oesophageal varices are enlarged veins within the lower oesophagus and the oesophagogastric junction which develop in patients with portal hypertension, often as a result of cirrhosis. Bleeding from ...